Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Optimizing Humira coverage is not just about reducing costs—it's about delivering effective, compassionate care while ...

The obesity medicine field has gained a new entrant, with AbbVie licensing an experimental drug from a Danish company.

AbbVie's strategic move into the obesity market through a partnership with Gubra A/S shows potential but won't impact revenue ...

Looking ahead to 2025, Sandoz said it expects net sales to grow by a mid-single digit percentage in constant currencies.

between Taltz and Humira, ask your doctor, insurance provider, or specialty pharmacy. They can provide more information about the exact cost of each medication for you. You can also visit Optum ...